J&J Stent Patents Found Invalid In Boston Sci Suit

By Elaine Meyer

Law360, New York (January 22, 2010, 10:43 AM ET) -- Boston Scientific Corp. has prevailed in a consolidated suit against Johnson & Johnson Inc., now that a federal judge has found invalid four J&J patents for a drug-eluting stent.

The summary judgment ruling Wednesday by Judge Sue L. Robinson of the U.S. District Court for the District of Delaware halted a trial that was to begin in February.

In a memorandum opinion, Judge Robinson held that the disputed claims of the four patents — which J&J alleged were infringed by the Promus stent system produced by...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles